Back to mobile site

Neurocrine Biosciences, Inc. (NBIX) Tops Q4 EPS by 1c

February 6, 2014 5:05 PM EST Send to a Friend
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q4 EPS of ($0.16) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login